Search Results

There are 5471 results for: content related to: Association between reported venlafaxine use in early pregnancy and birth defects, national birth defects prevention study, 1997–2007

  1. Establishing bioequivalence of racemic venlafaxine formulations using stereoselective assay method: Is it necessary?

    Chirality

    Volume 23, Issue 10, November 2011, Pages: 948–954, Kirti Kandhwal, Surajit Dey, Shabana Nazarudheen, Simrit Reyar, Sanjeev Mishra, Nageshwar R. Thudi, Arshad H. Khuroo and Tausif Monif

    Article first published online : 26 SEP 2011, DOI: 10.1002/chir.21021

  2. Changes in cardiovascular function after venlafaxine but not pregabalin in healthy volunteers: a double-blind, placebo-controlled study of orthostatic challenge, blood pressure and heart rate

    Human Psychopharmacology: Clinical and Experimental

    Volume 28, Issue 6, November 2013, Pages: 562–575, Alison Diaper, Ann S. Rich, Sue J. Wilson, Kevin Craig, Colin T. Dourish, Gerry R. Dawson, David J. Nutt and Jayne E. Bailey

    Article first published online : 16 AUG 2013, DOI: 10.1002/hup.2346

  3. Neuropharmacology of venlafaxine

    Depression and Anxiety

    Volume 12, Issue S1, 2000, Pages: 20–29, Patrick H. Roseboom and Ned H. Kalin

    Article first published online : 7 NOV 2000, DOI: 10.1002/1520-6394(2000)12:1+<20::AID-DA3>3.0.CO;2-M

  4. The treatment of depression with different formulations of venlafaxine: a comparative analysis

    Human Psychopharmacology: Clinical and Experimental

    Volume 19, Issue 1, January 2004, Pages: 9–16, James S. Olver, Graham D. Burrows and Trevor R. Norman

    Article first published online : 5 JAN 2004, DOI: 10.1002/hup.551

  5. Venlafaxine: Discrepancy between in vivo 5-HT and NE reuptake blockade and affinity for reuptake sites

    Synapse

    Volume 32, Issue 3, 1 June 1999, Pages: 198–211, Jean-Claude Béïque, Claude De Montigny, Pierre Blier and Guy Debonnel

    Article first published online : 29 APR 1999, DOI: 10.1002/(SICI)1098-2396(19990601)32:3<198::AID-SYN6>3.0.CO;2-2

  6. Venlafaxine and Nefazodone, Two Pharmacologically Distinct Antidepressants

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 17, Issue 3, May-June 1997, Pages: 511–530, Bruce G. Augustin, Julie A. Cold and Michael W. Jann

    Article first published online : 17 JAN 2012, DOI: 10.1002/j.1875-9114.1997.tb03060.x

  7. The disposition of venlafaxine enantiomers in dogs, rats, and humans receiving venlafaxine

    Chirality

    Volume 4, Issue 2, 1992, Pages: 84–90, C. Paul Wang, Stanley R. Howell, Joann Scatina and Samuel F. Sisenwine

    Article first published online : 21 SEP 2004, DOI: 10.1002/chir.530040204

  8. You have free access to this content
    Comparison of the effects of venlafaxine, desipramine, and paroxetine on noradrenaline- and methoxamine-evoked constriction of the dorsal hand vein

    British Journal of Clinical Pharmacology

    Volume 48, Issue 3, September 1999, Pages: 345–354, Abdelmawla, Langley, Szabadi and Bradshaw

    Article first published online : 24 DEC 2001, DOI: 10.1046/j.1365-2125.1999.00031.x

  9. You have free access to this content
    Venlafaxine oxidation in vitro is catalysed by CYP2D6

    British Journal of Clinical Pharmacology

    Volume 41, Issue 2, February 1996, Pages: 149–156, S. V. OTTON, S. E. BALL, S. W. CHEUNG, T. INABA, R. L. RUDOLPH and E. M. SELLERS

    Article first published online : 29 OCT 2008, DOI: 10.1111/j.1365-2125.1996.tb00173.x

  10. Antidepressant efficacy of venlafaxine

    Depression and Anxiety

    Volume 12, Issue S1, 2000, Pages: 45–49, Robert N. Golden and Linda Nicholas

    Article first published online : 7 NOV 2000, DOI: 10.1002/1520-6394(2000)12:1+<45::AID-DA5>3.0.CO;2-5

  11. Treatment of Pain Syndromes with Venlafaxine

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 24, Issue 5, May 2004, Pages: 621–629, Dale R. Grothe, Brian Scheckner and Dominick Albano

    Article first published online : 16 JAN 2012, DOI: 10.1592/phco.24.6.621.34748

  12. Therapeutic Options for Treating Major Depression, and the Role of Venlafaxine

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 16, Issue 3, May-June 1996, Pages: 352–365, Dr. Mollie A. Scott, Dr. Penny S. Shelton and Dr. Wendy Gattis

    Article first published online : 17 JAN 2012, DOI: 10.1002/j.1875-9114.1996.tb02965.x

  13. Absolute Bioavailability and Electroencephalographic Effects of Conventional and Extended-Release Formulations of Venlafaxine in Healthy Subjects

    The Journal of Clinical Pharmacology

    Volume 38, Issue 3, March 1998, Pages: 256–267, Dr. Alain Patat, Mr. Steven Troy, Dr. Jim Burke, Dr. Suzanne Trocherie, Dr. Philippe Danjou, Dr. Franck Le Coz, Dr. Hervé Allain and Dr. Jean-Marc Gandon

    Article first published online : 8 MAR 2013, DOI: 10.1002/j.1552-4604.1998.tb04423.x

  14. Extended release of a novel antidepressant, venlafaxine, based on anionic polyamidoamine dendrimers and poly(ethylene glycol)-containing semi-interpenetrating networks

    Journal of Biomedical Materials Research Part A

    Volume 72A, Issue 1, 1 January 2005, Pages: 107–114, Hu Yang and Stephanie T. Lopina

    Article first published online : 29 NOV 2004, DOI: 10.1002/jbm.a.30220

  15. You have free access to this content
    A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder

    Depression and Anxiety

    Volume 24, Issue 1, 2007, Pages: 1–14, Mark H. Pollack, Ulla Lepola, Hannu Koponen, Naomi M. Simon, John J. Worthington, Gerard Emilien, Evan Tzanis, Eliseo Salinas, Timothy Whitaker and Bo Gao

    Article first published online : 7 AUG 2006, DOI: 10.1002/da.20218

  16. Effect of Venlafaxine and Desvenlafaxine on Drug Efflux Protein Expression and Biodistribution In Vivo

    Journal of Pharmaceutical Sciences

    Volume 102, Issue 10, October 2013, Pages: 3838–3843, Corbin Bachmeier, Gary M. Levin, David Beaulieu-Abdelahad, Jon Reed and Michael Mullan

    Article first published online : 29 JUL 2013, DOI: 10.1002/jps.23680

  17. You have free access to this content
    Blockade of 5-Hydroxytryptamine and noradrenaline uptake by venlafaxine: a comparative study with paroxetine and desipramine

    British Journal of Pharmacology

    Volume 125, Issue 3, October 1998, Pages: 526–532, Jean-Claude Béïque, Claude de Montigny, Pierre Blier and Guy Debonnel

    Article first published online : 3 FEB 2009, DOI: 10.1038/sj.bjp.0702074

  18. Monoaminergic-based Pharmacotherapy for Depression

    Biology of Depression: From Novel Insights to Therapeutic Strategies

    George I. Papakostas, Maurizio Fava, Pages: 87–209, 2008

    Published Online : 29 JAN 2008, DOI: 10.1002/9783527619672.ch6

  19. Pharmacokinetic Interaction Between Multiple-Dose Venlafaxine and Single-Dose Lithium

    The Journal of Clinical Pharmacology

    Volume 36, Issue 2, February 1996, Pages: 175–181, Mr. Steven M. Troy, Dr. Vernon D. Parker, Dr. David R. Hicks, Dr. F. Douglas Boudino and Dr. Soong T. Chiang

    Article first published online : 8 MAR 2013, DOI: 10.1002/j.1552-4604.1996.tb04183.x

  20. Symptoms of delusion: the effects of discontinuation of low-dose venlafaxine

    Acta Psychiatrica Scandinavica

    Volume 120, Issue 4, October 2009, Pages: 329–331, M. Koga, F. Kodaka, H. Miyata and K. Nakayama

    Article first published online : 1 JUL 2009, DOI: 10.1111/j.1600-0447.2009.01433.x